Hydrobromides
Medchemexpress LLC Burixafor hydrobromide | 1191450-19-7 | 98.0% | 769.01 | C27H51N8O3P·5/2 HBr | 10 MG
Burixafor hydrobromide is the hydrobromide salt of burixafor, a selective, orally active CXCR4 antagonist supplied as a research reagent for preclinical and in vitro studies of CXCR4-mediated biology, including cancer metastasis, angiogenesis, and hematopoietic stem cell mobilization.
- Selective CXCR4 antagonist for receptor-targeted studies.
- High purity (98.0%) suitable for research applications.
- Water soluble (≈50 mg/mL) with ultrasonic assistance.
- Solid, light yellow to yellow appearance for easy handling.
- Recommended storage at -20°C under nitrogen for stability.
- Available in small research quantity (10 MG).
eMolecules Ambeed 3-Bromopiperidine-2 6-dione 250mg 506392068 A875928 0 000 62595-74-8 MFCD11053059 192 012 C5H6BrNO2
Ambeed 3-Bromopiperidine-2 6-dione 250mg 506392068 A875928 0 000 62595-74-8 MFCD11053059 192 012 C5H6BrNO2
Medchemexpress LLC Anisodamine hydrobromide | 55449-49-5 | 99.5% | 386.28 g/mol | C17H24BrNO4 | 10 MG
Anisodamine hydrobromide is the hydrobromide salt of anisodamine (6-hydroxyhyoscyamine), a belladonna alkaloid with muscarinic and nicotinic receptor activity. It is supplied as a high-purity research reagent for pharmacology and biochemical studies; not for clinical use.
- High purity (approximately 99.5%).
- Molecular weight 386.28 g/mol.
- Hydrobromide salt increases water solubility for aqueous assays.
- Supplied in small milligram quantities suitable for analytical and preclinical research.
- Commonly used in muscarinic receptor pharmacology and biochemical research applications.
Apexbio Technology LLC Arecoline hydrobromide 300-08-3 1g
Arecoline hydrobromide (CAS 300-08-3) is a nicotinic alkaloid that acts as a partial agonist at muscarinic acetylcholine receptors M1 M4 In electrophysiological studies it significantly inhibits the hERG potassium channel current with an IC50 of 9 55 mol/L The compound s inhibitory effect on IhERG displays concentration time and voltage dependency with blockade intensity influenced by stimulation frequency Subcutaneous administration in mice yields an LD50 of 100 mg/kg Arecoline hydrobromide is utilized in research on cardiac electrophysiology and muscarinic receptor pharmacology particularly for investigating frequency- and state-dependent modulation of cardiac ion channels
Apexbio Technology LLC Arecoline hydrobromide 300-08-3 500mg
Arecoline hydrobromide (CAS 300-08-3) is a nicotinic alkaloid that acts as a partial agonist at muscarinic acetylcholine receptors M1 M4 In electrophysiological studies it significantly inhibits the hERG potassium channel current with an IC50 of 9 55 mol/L The compound s inhibitory effect on IhERG displays concentration time and voltage dependency with blockade intensity influenced by stimulation frequency Subcutaneous administration in mice yields an LD50 of 100 mg/kg Arecoline hydrobromide is utilized in research on cardiac electrophysiology and muscarinic receptor pharmacology particularly for investigating frequency- and state-dependent modulation of cardiac ion channels